REZO THERAPEUTICS, INC.
Profile
Company Names
REZO THERAPEUTICS, INC.
Addresses
455 MISSION BAY BOULEVARD SOUTH, SUITE 525, SAN FRANCISCO, CA 94158
Phone Numbers
415-310-4524
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2021
State Incorporated:
DELAWARE
Total Amount Raised:
$68,066,039.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-07-21
$68,066,039.00
$80,129,936.00
$12,063,897.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
VINEETA
AGARWALA
DIRECTOR
TIBA
AYNECHI
DIRECTOR
THESAN PHARMACEUTICALS, INC.
| IRHYTHM TECHNOLOGIES, INC.
| ANAPTYSBIO INC
| GENOA PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| ARCELLX, INC.
| NKARTA, INC.
| AVALYN PHARMA INC.
| SPRUCE BIOSCIENCES, INC.
| ARISTEA THERAPEUTICS, INC.
| MBX BIOSCIENCES, INC.
| REZO THERAPEUTICS, INC.
| RAY THERAPEUTICS, INC.
SIMEON
GEORGE
DIRECTOR
SEMPRUS BIOSCIENCES CORP
| GENOCEA BIOSCIENCES, INC.
| HTG MOLECULAR DIAGNOSTICS INC
| AUXOGYN INC
| EFFECTOR THERAPEUTICS, INC.
| HTG MOLECULAR DIAGNOSTICS, INC
| AUXOGYN, INC.
| PRINCIPIA BIOPHARMA INC.
| PROGYNY, INC.
| TP THERAPEUTICS, INC.
| CRISPR THERAPEUTICS AG
| SR ONE CO-INVEST I, LLC
| SIMCHA THERAPEUTICS HOLDING COMPANY, LLC
| ADARX PHARMACEUTICALS, INC.
| SR ONE CAPITAL FUND II-B, LP
| SR ONE CAPITAL FUND II-A, LP
| AVENZO THERAPEUTICS, INC.
| REZO THERAPEUTICS, INC.
| SR ONE CAPITAL FUND III, LP
GEORGE
SCANGOS
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

